Pherecydes Pharma SA - ESG Rating & Company Profile powered by AI
Full ESG analysis of Pherecydes Pharma SA are reached by signing up for free. The ESG score for Pherecydes Pharma SA indicates the company's reporting of the United Nations SDGs. If you work at Pherecydes Pharma SA and you wish to licence your ESG aseessment, please get in touch.
Pherecydes Pharma SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.8; made up of an environmental score of 0.0, social score of 2.7 and governance score of 2.7.
1.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1617 | Berry Genomics Co Ltd | 1.9 | Low |
| 1617 | scPharmaceuticals Inc | 1.9 | Low |
| 1631 | Pherecydes Pharma SA | 1.8 | Low |
| 1631 | Cannabis Global, Inc. | 1.8 | Low |
| 1631 | Cannabis Strategic Ventures | 1.8 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Pherecydes Pharma SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Pherecydes Pharma SA report the average age of the workforce?
Sign up for free to unlockDoes Pherecydes Pharma SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose cybersecurity risks?
Sign up for free to unlockDoes Pherecydes Pharma SA offer flexible work?
Sign up for free to unlockDoes Pherecydes Pharma SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pherecydes Pharma SA conduct supply chain audits?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pherecydes Pharma SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose water use targets?
Sign up for free to unlockDoes Pherecydes Pharma SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Pherecydes Pharma SA have a product recall in the last two years?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose incidents of discrimination?
Sign up for free to unlockDoes Pherecydes Pharma SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pherecydes Pharma SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose parental leave metrics?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pherecydes Pharma SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pherecydes Pharma SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pherecydes Pharma SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose its waste policy?
Sign up for free to unlockDoes Pherecydes Pharma SA report according to TCFD requirements?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose energy use targets?
Sign up for free to unlockDoes Pherecydes Pharma SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pherecydes Pharma SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pherecydes Pharma SA
These potential risks are based on the size, segment and geographies of the company.
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.